Archives of Medical Science
Evaluation and identification of damaged single nucleotide polymorphisms in COL1A1 gene involved in osteoporosis
Tariq Ahmad Masoodi, Mohammed A. Alsaif, Sulaiman A. Al Shammari, Adel A. Alhamdan
Arch Med Sci 2013; 9, 5: 899–905
DOI (digital object identifier): 10.5114/aoms.2012.28598
documents in PDF format:
- Evaluation and.pdf [0.12 MB]
IntroductionOsteoporosis, a serious skeletal disease commonly observed among the elderly, is associated with substantial morbidity and socio-economic burden [1, 2]. In the United States alone, more than 40 million people either already have osteoporosis or are at high risk due to low bone mass [http://www. niams.nih.gov/Health_Info/Bone/Osteoporosis/osteoporosis_ff. asp]. In Saudi Arabia, a high prevalence of osteoporosis in the elderly has been observed . It is diagnosed when the bone mineral density (BMD) is greater than 2.5 standard deviations below peak bone mass according to the criteria of the World Health Organization . Osteoporosis can occur in both men and women and at any age, but it is most common in older women. It has been reported that one in two women and one in 5 men over the age of 50 sustain fractures due to osteoporosis . Collagen type I 1 (COL1A1) encodes the primary subunit of -1-chain type I collagen, the main structural and most abundant protein in bone. Within this gene, > 400 human disease-associated mutations have been identified, the majority of which are linked to osteoporosis. The COLIA1 gene is a strong functional candidate for the genetic regulation of bone mass and susceptibility to fragility fractures .
Single-nucleotide polymorphisms (SNPs) are the most common mutations of DNA sequence variation for mapping complex genetic traits. About 500,000 SNPs fall within the coding regions of the human genome. Among these, the non-synonymous SNPs cause changes in the amino acid residues. These are likely to be an important factor contributing to the functional diversity of the encoded proteins in the human population . It has been worked out that non-synonymous SNPs (nsSNPs) affect the functional roles of proteins in the signal transduction of visual, hormonal, and other stimulants [7, 8]. These nsSNPs affect gene expression by modifying DNA and transcription factor binding [9, 10] and deactivate active sites of enzymes or change splice sites, thereby producing defective gene products [11, 12].
Epidemiological association studies focus a great amount of effort on identifying SNPs in genes that may have an association with disease risk, and often the SNPs that have an association with disease are non-synonymous. Many molecular epidemiological studies focus on studying SNPs found in coding regions in the hope of finding significant association between SNPs and disease susceptibility, but often find little or no association . With the availability of high-throughput SNP detection techniques, the population of nsSNPs is increasing rapidly, providing a platform for studying the relationship between genotypes and phenotypes of human diseases. Our ability to better select an nsSNP for an association study can be enhanced by first examining the potential impact an amino acid variant may have on the function of the encoded protein using different SNP detection programs such as I-Mutant, Sort Intolerant from Tolerant (SIFT) and Polymorphism Phenotype (PolyPhen) . Discovering the deleterious nsSNPs out of a pool of all the SNPs will be very useful for epidemiological population-based studies.
So the main aim of this study is to identify deleterious nsSNPs associated with the COL1A1 gene.
Material and methodsMethodology
Methodology used was the same as described earlier [6, 13, 14].
SNP dataset from dbSNP
This computational analysis used Single Nucleotide Polymorphism Database (dbSNP) (http://www. ncbi.nlm.nih.gov/SNP/) to identify SNPs and their related protein sequence for the COL1A1 gene .
Analysis of protein stability change by I-Mutant 2.0
We predicted nsSNP causing protein stability change using the I-Mutant 2.0 tool  available from the University of Bologna (http://gpcr.biocomp. unibo.it/). I-Mutant 2.0 is a support vector machine (SVM) based tool for the automatic prediction of protein stability change upon single amino acid substitution. The protein stability change was predicted from the COL1A1 protein sequence (NP_000079). The software computed the predicted free energy change value or sign (DDG) which is calculated from the unfolding Gibbs free energy value of the mutated protein minus the unfolding Gibbs free energy value of the native protein (kcal/mol). A positive DDG value indicates that the mutated protein possesses high stability and vice versa.
Evaluation of coding single nucleotide polymorphisms
There are many web-based resources available that allow one to predict whether non-synonymous coding SNPs may have functional effects on proteins. We chose SIFT  available from http://sift.jcvi. org/ to perform protein conservation analysis and predict the phenotypic effect of amino acid substitutions. The SIFT is based on the premise that protein evolution is correlated with protein function. Variants that occur at conserved alignment positions are expected to be tolerated less than those that occur at diverse positions. The algorithm uses a modified version of PSIBLAST  and Dirichlet mixture regularization  to construct a multiple sequence alignment of proteins that can be globally aligned to the query sequence and belong to the same clade. The underlying principle of this program is that it generates alignments with a large number of homologous sequences and assigns scores to each residue, ranging from zero to one. The SIFT scores 0.05 are predicted by the algorithm to be intolerant or deleterious amino acid substitutions, whereas scores > 0.05 are considered tolerant . The higher the tolerance index of a particular amino acid substitution, the smaller is its likely impact.
Simulation of functional change in nsSNP by PolyPhen server
PolyPhen  available from Harvard School of Medicine (http://genetics.bwh.harvard.edu/pph/) is a computational tool for identification of potentially functional nsSNPs. Predictions are based on a combination of phylogenetic, structural and sequence annotation information characterizing a substitution and its position in the protein. For a given amino acid variation, PolyPhen performs several steps: (a) extraction of sequence-based features of the substitution site from the UniProt database, (b) calculation of profile scores for two amino acid variants, (c) calculation of structural parameters and contacts of a substituted residue. PolyPhen scores were classified as ‘benign’ or ‘probably damaging’ . Input options for the PolyPhen server are protein sequence or accession number together with sequence position with two amino acid variants. We submitted the query in the form of a protein sequence with mutational position and two amino acid variants. PolyPhen searches for three-dimensional protein structures, multiple alignments of homologous sequences and amino acid contact information in several protein structure databases. Then it calculates position-specific independent count (PSIC) scores for each of two variants, and computes the difference of the PSIC scores of the two variants. The higher a PSIC score difference, the higher the functional impact a particular amino acid substitution is likely to have. A PSIC score difference of 1.5 or above is considered to be damaging.
Analysis of functional nsSNPs and estimation of risk score by FASTSNP
The Functional Analysis and Selection Tool for Single Nucleotide Polymorphism (FASTSNP) is a web server (http://fastsnp.ibms.sinica.edu.tw/) which connects many programs and databases for processing analysis . We used FASTSNP for the prediction of the functional effect of nsSNPs and estimation of their risk score. FASTSNP uses a decision tree for prioritizing the functional effect and estimating risk score. The nsSNPs were submitted for FASTSNP analysis and output files were displayed as a decision tree.
ResultsSNP dataset from dbSNP
The COL1A1 gene investigated in this work was retrieved from the dbSNP database. It contained a total of 716 SNPs, of which 247 were nsSNPs, 25 were synonymous SNPs, and 32 were in non-coding regions, which comprise 1 SNP in the 5’ UTR and 31 SNPs in the 3’ UTR. The rest were in the intron region. We selected non-synonymous coding SNPs for our investigation.
Identification of functional nsSNP by I-Mutant 2.0
The more negative the free energy value (DDG value), the more likely a given point mutation is to be less stable and deleterious. We obtained 23 nsSNPs that were found to be less stable by this server, as shown in Table I. Out of 23 nsSNPs, 5 nsSNPs, namely rs1059454, rs17853657, rs17857117, rs41316719 and rs72656344, showed a DDG value of > –1.0. The remaining nsSNPs showed a DDG value of < –1.0, as depicted in Table I. Out of 23 nsSNPs that showed negative DDG, three nsSNPs, namely rs17853657, rs17857117and rs57377812, changed their amino acid from non-polar to polar amino acid, and two nsSNPs, namely rs1059454 and rs72656307, changed their amino acids from polar to non-polar. Four nsSNPs, namely rs1135345, rs1800211, rs72656344 and rs72656351, changed their amino acid from polar to polar mutation and the remaining ones changed from non-polar to non-polar mutation. Since the amino acid mutations in the first five nsSNPs changed their physiochemical properties, we considered these nsSNPs to be less stable and deleterious by this analysis.
Predictions of deleterious and damaging coding nsSNPs
Protein conservation analysis was performed using a sequence-homology based tool, SIFT. Two hundred and forty-seven nsSNPs retrieved from the COL1A1 gene were submitted independently to the SIFT program to check its tolerance index. Our results showed that 19 nsSNPs were deleterious, having a tolerance index score of 0.05. The results are shown in Table I. We observed that, out of 19 deleterious nsSNPs, 12 nsSNPs showed a highly deleterious tolerance index score of 0.00. Among these deleterious 19 nsSNPs, two nsSNPs showed a nucleotide change from AG, one from AC, one from CT, two from CG and the other 13 from GT (Table I). Also, according to the SIFT results, three nsSNPs, namely rs17853657, rs17857117 and rs57377812, changed their amino acid from non-polar to polar amino acid, and one nsSNP, namely rs1059454, changed its amino acid from polar to non-polar amino acid in the mutant protein. We found that these four nsSNPs that are seen to be deleterious according to SIFT were also found less stable by the I-Mutant 2.0 server. Therefore, these four nsSNPs were found deleterious by this investigation.
Identification of damaged COL1A1 nsSNPs by PolyPhen server
To identify the COL1A1 nsSNPs that affected protein structure, the COL1A1 nsSNPs were analyzed for predicting a possible impact of amino acids on the structure and function of the protein using the PolyPhen server. The COL1A1 protein sequence (NP_000079) with each nsSNP position and their 2 amino acid variants was submitted as input for analyzing the protein structural change due to amino acids. Our result showed 7 nsSNPs, namely rs1059454, rs8179178, rs17853657, rs17857117, rs72656340, rs72656344 and rs72656351, to be probably damaging, with a PSIC score difference between 2.0 and 3.5. The rs1059454, rs17853657 and rs17857117 which were observed to be the cause of protein lower stability by the I-Mutant 2.0 server and SIFT were also predicted to be probably damaging by the PolyPhen server. In addition, the other four nsSNPs are highly confidently predicted as probably damaging nsSNPs and the remainder as benign by PolyPhen (Table I).
Investigation of functional effect and estimated risk of COL1A1 nsSNPs
In order to identify nsSNPs with a high possibility of having a functional effect, FASTSNP was applied for the detection of nsSNP influence on cellular and molecular biological function, e.g. transcriptional and splicing regulation. In addition the estimation of risk score was also calculated by FASTSNP. The functional effect and estimated risk of COL1A1 nsSNPs are shown in Table II. Eight COL1A1 nsSNPs exhibited a medium-high risk score (risk score = 3-4). The functional nsSNPs were rs1059454, rs8179178, rs17853657, rs17857117, rs41316713, rs41316719, rs72656312 and rs72656329. The remaining nsSNPs showed low-medium risk (risk score = 2-3). The two functional nsSNPs (rs72656329 and rs41316719) detected by FASTSNP were also predicted to be polymorphic by I-Mutant 2.0 and SIFT. The nsSNPs rs72656312 and rs41316713 were also predicted to be deleterious by SIFT. The nsSNP rs8179178 was also predicted to be functionally damaging by SIFT and PolyPhen software. But the most important finding detected by FASTSNP was the three nsSNPs, namely rs1059454, rs17853657 and rs17857117, that were also found polymorphic by I-Mutant 2.0, SIFT as well as by PolyPhen.
DiscussionOur analysis revealed 247 SNPs as non-synonymous out of which 5 nsSNPs, namely rs1059454, rs17853657, rs17857117, rs41316719 and rs72656344, were found to be least stable by I-Mutant 2.0 with a DDG value of > –1.0. Four nsSNPs, namely rs17853657, rs17857117, rs57377812 and rs1059454, showed a highly deleterious tolerance index score of 0.00 with a change in their physicochemical properties by the SIFT server. Seven nsSNPs, namely rs1059454, rs8179178, rs17853657, rs17857117, rs72656340, rs72656344 and rs72656351, were found to be probably damaging, with a PSIC score difference between 2.0 and 3.5 by the PolyPhen server. Three nsSNPs, namely rs1059454, rs17853657 and rs17857117, were found to be highly polymorphic with a risk score of 3-4 with a possible effect of non-conservative change and splicing regulation by FASTSNP.
A major interest in human genetics is to distinguish mutations that are functionally neutral from those that contribute to disease. Amino acid substitutions currently account for approximately half of the known gene lesions responsible for human inherited disease. Therefore, the identification of nsSNPs that affect protein functions and relate to disease is an important task. The effect of many nsSNPs will probably be neutral as natural selection will have removed mutations at essential positions. Assessment of non-neutral SNPs is mainly based on phylogenetic information (i.e. correlation with residue conservation) extended to a certain degree with structural approaches. However, there is increasing evidence that many human disease genes are the result of exonic or non-coding mutations affecting regulatory regions . Much attention has been focused on modeling by different methods the possible phenotypic effect of SNPs that cause amino acid changes, and only recently has interest focused on functional SNPs affecting regulatory regions or the splicing process. Moreover, because of their widespread distribution on the species genome, SNPs are particularly important and valuable as genetic makers in research on diseases and the corresponding drugs. To date, millions of human SNPs have been reported by high-throughput methods. The vast number of SNPs causes a challenge for biologists and bioinformaticians although they provide a lot of information about the relationships between individuals. Besides numerous ongoing efforts to identify millions of these SNPs, there is now also a focus on studying associations between disease risk and these genetic variations using a molecular epidemiological approach. This plethora of SNPs points out a major difficulty faced by scientists in planning costly population-based genotyping, which is to choose target SNPs that are most likely to affect phenotypic functions and ultimately contribute to disease development .
Currently, most molecular studies focus on SNPs located in coding and regulatory regions, yet many of these studies have been unable to detect significant associations between SNPs and disease susceptibility. To develop a coherent approach for prioritizing SNP selection for genotyping in molecular studies, an evolutionary perspective to SNP screening is applied. The hypothesis is that amino acids conserved across species are more likely to be functionally significant. Therefore, SNPs that change these amino acids might be more likely to be associated with disease susceptibility. It is becoming clear that application of the molecular evolutionary approach may be a powerful tool for prioritizing SNPs to be genotyped in future molecular epidemiological studies . Therefore, our analysis will provide useful information in selecting SNPs of the COL1A1 gene that are likely to have a potential functional impact.
Although computational tools show their potential in reducing the number of nsSNPs for disease association studies by filtering nsSNPs that are most likely to be disease related, error predictions do occur. Various computational tools used in this analysis determine the functional effects of SNPs only with respect to a single biological function. Therefore, much time and effort is required from researchers to identify the appropriate tools and interpret the predictions. There are also some aspects affecting the prediction correctness for prediction programs like SIFT and PolyPhen. SIFT and PolyPhen depend on diverse databases for SNP information. Polluted databases with incorrect SNP reports and bias of the data towards disease-associated allelic variants are likely to lead to over-prediction of the number of deleterious nsSNPs . Furthermore, tools finding SNPs may identify base alterations between the functional gene and a pseudogene and mistakenly report these alterations as SNPs in the functional protein. Including nsSNPs mistakenly mapped from pseudogenes in the SNP database will affect the prediction accuracy of predictive tools using SNP information from these databases .
In conclusion, in our analysis, three nsSNPs (rs1059454, rs17853657 and rs17857117) were found to be less stable, deleterious, probably damaging and to have a high risk score by I-Mutant 2.0, SIFT, PolyPhen and FASTSNP, respectively. We therefore conclude that these three nsSNPs are potentially functionally polymorphic. To those conducting large-scale population-based epidemiological studies, the idea of prioritizing nsSNPs in the investigation of association of SNPs with disease risk is of great interest. The use of these servers to select potentially polymorphic nsSNPs for epidemiological studies can be an efficient way to explore the role of genetic variation in disease risk and to curtail cost. Furthermore, the predicted impact of these nsSNPs can be tested using animal models or cell lines to determine whether functionality of the protein has indeed been altered.
References1. Yazici S, Korkmaz U, Erkan M, et al. The effect of breast-feeding duration on bone mineral density in postmenopausal Turkish women: a population-based study. Arch Med Sci 2011; 7: 486-92.
2. Sadat-Ali M, AlElq A. Osteoporosis among male Saudi Arabs: a pilot study. Ann Saudi Med 2006; 26: 450-4.
3. Dolan P, Torgerson DJ. The cost of treating osteoporotic fractures in the United Kingdom female population. Osteoporos Int 2000; 11: 551-2.
4. Aronow WS. Osteoporosis, osteopenia, and atherosclerotic vascular disease. Arch Med Sci 2011; 7: 21-6.
5. Stover DA, Verrelli BC. Comparative vertebrate evolutionary analyses of type I collagen: potential of COL1a1 gene structure and intron variation for common bone-related diseases. Mol Biol Evol 2011; 28: 533-42.
6. Rajasekaran R, Sudandiradoss C, Doss CG, Sethumadhavan R. Identification and in silico analysis of functional SNPs of the BRCA1 gene. Genomics 2007; 90: 447-52.
7. Dryja TP, McGee TL, Hahn LB, at al. Mutations within the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa. N Engl J Med 1990; 323: 1302-7.
8. Smith EP, Boyd J, Frank GR, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 1994; 331: 1056-61.
9. Barroso I, Gurnell M, Crowley VE, et al. Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 1999; 402: 880-3.
10. Thomas R, McConnell R, Whittacker J, Kirkpatrick P, Bradley J, Sandford R. Identification of mutations in the repeated part of the autosomal dominant polycystic kidney disease type 1 gene, PKD1, by long-range PCR. Am J Hum Genet 1999; 65: 39-49.
11. Yoshida A, Huang IY, Ikawa M. Molecular abnormality of an inactive aldehyde dehydrogenase variant commonly found in Orientals. Proc Natl Acad Sci U S A 1984; 81: 258-61.
12. Jaruzelska J, Abadie V, d’Aubenton-Carafa Y, Brody E, Munnich A, Marie J. In vitro splicing deficiency induced by a C to T mutation at position -3 in the intron 10 acceptor site of the phenylalanine hydroxylase gene in a patient with phenylketonuria. J Biol Chem 1995; 270: 20370-5.
13. Johnson MM, Houck J, Chen C. Screening for deleterious nonsynonymous single-nucleotide polymorphisms in genes involved in steroid hormone metabolism and response. Cancer Epidemiol Biomarkers Prev 2005; 14: 1326-9.
14. Doss CG, Sethumadhavan R. Investigation on the role of nsSNPs in HNPCC genes – a bioinformatics approach. J Biomed Sci 2009; 16: 42.
15. Sherry ST, Ward MH, Kholodov M, et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 2001; 29: 308-11.
16. Capriotti E, Fariselli P, Casadio R. I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Res 2005; 33: w306-10.
17. Ng PC, Henikoff S. Predicting deleterious amino acid substitutions. Genome Res 2001; 11: 863-74.
18. Altschul SF, Madden TL, Schäffer AA, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997; 25: 3389-402.
19. Sjölander K, Karplus K, Brown M, et al. Dirichlet mixtures: a method for improved detection of weak but significant protein sequence homology. Comput Appl Biosci 1996; 12: 327-45.
20. Ng PC, Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucl Acids Res 2003; 31: 3812-4.
21. Sunyaev S, Ramensky V, Bork P. Towards a structural basis of human non-synonymous single nucleotide polymorphisms. Trends Genet 2000; 16: 198-200.
22. Xi T, Jones IM, Mohrenweiser HW. Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function. Genomics 2004; 83: 970-9.
23. Yuan HY, Chiou JJ, Tseng WH, et al. FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res 2006; 34: W635-41.
24. Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res 2002; 30: 3894-900.
25. Ng PC, Henikoff S. Accounting for human polymorphisms predicted to affect protein function. Genome Res 2002; 12: 436-46.
Ten materiał jest chroniony prawami autorskimi. Wykorzystywanie do dalszego rozpowszechniania bez zgody właściciela praw autorskich jest zabronione. Zobacz regulamin korzystania z serwisu www.termedia.pl.
Wytyczne i badania kliniczne – Kardiologia 2009. Nie tylko dla lekarzy specjalistów
pod redakcją Macieja Banacha i Zbigniewa Gacionga
liczba stron 240
pod redakcją Arkadiusza Jawienia
i Marii T. Szewczyk
liczba stron 152